SINOPHARM GRP CO. H YC 1 earnings per share and revenue

X2S earnings per share for the last semiannual are 0.19 EUR whereas the estimation was 0.19 EUR which accounts for 0.00% surprise. Company revenue for the same period amounts to 39.08 B EUR despite the estimated figure of 39.08 B EUR. Estimated earnings per share for the next semiannual are 0.16 EUR, and revenue is expected to reach 41.74 B EUR. Also watch annual changes over time to get a bigger picture of X2S earnings per share and revenue dynamics.